Literature DB >> 2698313

The nature and significance of osteopontin.

W T Butler1.   

Abstract

Osteopontin is an acidic glycoprotein of about 41,500 daltons that has been isolated from rat, human and bovine bone. It is rich in aspartic acid, glutamic acid and serine and contains about 30 monosaccharides, including 10 sialic acids. Several types of data suggest that the carbohydrate is present as 1 N-glycoside and 5-6 O-glycosides while the phosphate is present as 12 phosphoserines and 1 phosphothreonine. The cDNA sequence indicated the presence of a Gly-Arg-Gly-Asp-Ser- (GRGDS) amino acid sequence identical to a cell binding sequence in fibronectin, and suggested that osteopontin might function as a cell attachment factor. This conclusion is supported by a number of studies showing that the protein promotes attachment and spreading of fibroblasts and osteoblasts to substratum, and that this attachment is inhibited by RGD-containing peptides. Despite this evidence that it contains an RGD recognition sequence and probably interacts with the family of receptors known as integrins, it appears that osteopontin does not possess a collagen-binding domain. Osteopontin is synthesized by preosteoblasts, osteoblasts and osteocytes, is secreted into osteoid and is incorporated into bone. The expression at an early developmental stage is an indication that osteopontin is an important component in the formation of bone. The level of synthesis of osteopontin by osteoblasts in culture is increased by treating these cells with 1,25-dihydroxyvitamin D3 and TGF-beta. The effect of these agents is at the transcriptional level. In addition to bone cells, osteopontin is synthesized by extraosseous cells in the inner ear, brain, kidney, and deciduum and placenta. It is also synthesized by odontoblasts, certain bone marrow cells and hypertrophic chondrocytes. Studies with several fibroblast and epithelial-derived cell lines in culture indicate that secretion of osteopontin can be dramatically increased when these cells are treated with phorbol esters, growth factors and hormones. However, osteopontin does not appear to be expressed by mesenchymal cells, fibroblasts, epidermal cells or by most epithelial cells in vivo.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2698313     DOI: 10.3109/03008208909002412

Source DB:  PubMed          Journal:  Connect Tissue Res        ISSN: 0300-8207            Impact factor:   3.417


  95 in total

1.  Distinctive expression of extracellular matrix molecules at mRNA and protein levels during formation of cellular and acellular cementum in the rat.

Authors:  Y Sasano; Y Maruya; H Sato; J X Zhu; I Takahashi; I Mizoguchi; M Kagayama
Journal:  Histochem J       Date:  2001-02

2.  Osteopontin reduced hypoxia-ischemia neonatal brain injury by suppression of apoptosis in a rat pup model.

Authors:  Wanqiu Chen; Qingyi Ma; Hidenori Suzuki; Richard Hartman; Jiping Tang; John H Zhang
Journal:  Stroke       Date:  2011-01-27       Impact factor: 7.914

3.  Osteoblastic meningiomas: clinico-pathological and immunohistochemical features of an uncommon variant.

Authors:  V Barresi; M Caffo; A Ieni; C Alafaci; G Tuccari
Journal:  J Neurooncol       Date:  2011-04-22       Impact factor: 4.130

4.  Enhancement of drug delivery: enzyme-replacement therapy for murine Morquio A syndrome.

Authors:  Shunji Tomatsu; Adriana M Montaño; Vu Chi Dung; Amiko Ohashi; Hirotaka Oikawa; Toshihiro Oguma; Tadao Orii; Luis Barrera; William S Sly
Journal:  Mol Ther       Date:  2010-03-23       Impact factor: 11.454

5.  Osteopontin expression in ductal adenocarcinomas and undifferentiated carcinomas of the pancreas.

Authors:  R Sedivy; K Peters; G Klöppel
Journal:  Virchows Arch       Date:  2004-11-26       Impact factor: 4.064

6.  Fluid flow increases mineralized matrix deposition in 3D perfusion culture of marrow stromal osteoblasts in a dose-dependent manner.

Authors:  Gregory N Bancroft; Vassilios I Sikavitsas; Juliette van den Dolder; Tiffany L Sheffield; Catherine G Ambrose; John A Jansen; Antonios G Mikos
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-19       Impact factor: 11.205

Review 7.  Protein biomarkers of epileptogenicity after traumatic brain injury.

Authors:  Denes V Agoston; Alaa Kamnaksh
Journal:  Neurobiol Dis       Date:  2018-07-17       Impact factor: 5.996

8.  A novel biological function for CD44 in axon growth of retinal ganglion cells identified by a bioinformatics approach.

Authors:  Albert Ries; Jeffrey L Goldberg; Barbara Grimpe
Journal:  J Neurochem       Date:  2007-08-30       Impact factor: 5.372

9.  Osteopontin Attenuates Secondary Neurodegeneration in the Thalamus after Experimental Stroke.

Authors:  Anne Ladwig; Rebecca Rogall; Jörg Hucklenbroich; Antje Willuweit; Michael Schoeneck; Karl-Josef Langen; Gereon R Fink; M Adele Rueger; Michael Schroeter
Journal:  J Neuroimmune Pharmacol       Date:  2018-11-28       Impact factor: 4.147

10.  Bone-targeting of quinolones conjugated with an acidic oligopeptide.

Authors:  Tatsuo Takahashi; Koichi Yokogawa; Naoki Sakura; Masaaki Nomura; Shinjiro Kobayashi; Ken-ichi Miyamoto
Journal:  Pharm Res       Date:  2008-07-29       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.